PARATEK PHARMACEUTICALS INC

BOSTON, MA · CIK 0001037643 · Biotech · Acquired

Tetracycline-class antibiotics and novel antimicrobial therapeutics

paratekpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$93M
1 Form D · Jul 2014
147 months since last filing
Contracts
—
No federal contracts on record
Patents
40
7 granted · 33 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$93,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2209ARIETIS CORPORATION——
2210MBX Biosciences—$95M
2211TECTARIA BIO LLC——
2212PARATEK PHARMACEUTICALS INC—$93M
2213Milestone Pharmaceuticals Inc.—$91M
2214BE COOL PHARMACEUTICS, LLC——
2215Xeris Pharmaceuticals, Inc.—$80M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Beverly ArmstrongExecutive Officer
  • Michael BighamDirector · Executive Officer
  • Kathryn BoxmeyerExecutive Officer
  • Sean JohnstonExecutive Officer
  • Richard LimDirector
  • Evan LohDirector · Executive Officer
  • Dennis MolnarExecutive Officer
  • S. TanakaExecutive Officer

Patents

USPTO · 7 granted of 40
  • Methods For Synthesizing And Purifying Aminoalkyl Tetracycline Compoundsapplication
  • Salts And Polymorphs Of A Tetracycline Compoundapplication
  • Substituted Tetracycline Compounds For Treatment Of Inflammatory Skin Disordersapplication
  • Substituted Tetracycline Compoundsapplication
  • Oral And Injectable Formulations Of Tetracycline Compoundsapplication
  • Minocycline Compounds For Biodefenseapplication
  • Methods For Synthesizing Substituted Tetracycline Compoundsapplication
  • 9-AMINOMETHYL Minocycline Compounds And Uses Thereofapplication
  • Minocycline Compounds And Methods Of Use Thereofapplication
  • 9-AMINOMETHYL Minocycline Compounds And Use Thereof In Treating Community-acquired Bacterial Pneumonia (cabp)application
  • Methods For Treating And Preventing C. Difficile Infectionapplication
  • Minocycline Compounds For Biodefenseapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.